Digitisation | September 05, 2023
Shareholding of the company in MIMS has increased from 76.01 per cent to 78.37 per cent
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
APAC to see a reduction in imported surgical robotics
OrderPoint was designed as an advanced DTR solution from its first release in 2016.
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics
Subscribe To Our Newsletter & Stay Updated
